世界のオピオイド薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Opioid Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5910 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、オピオイド薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、フェンタニル、ヒドロコドン、モルヒネ、オキシコドン、トラマドール、その他）、用途別市場規模（麻酔、鎮痛、咳抑制、下痢抑制、中毒解消、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・オピオイド薬の市場動向 ・企業の競争状況、市場シェア ・オピオイド薬の種類別市場規模と予測2016-2027（ブプレノルフィン、フェンタニル、ヒドロコドン、モルヒネ、オキシコドン、トラマドール、その他） ・オピオイド薬の用途別市場規模と予測2016-2027（麻酔、鎮痛、咳抑制、下痢抑制、中毒解消、その他） ・オピオイド薬の北米市場規模2016-2027（アメリカ、カナダ） ・オピオイド薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・オピオイド薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・オピオイド薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・オピオイド薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acura Pharmaceuticals、Cipher Pharmaceutical Inc.、Daiichi Sankyo、Johnson＆Johnson、Lupin Limited、Pfizer、Sun Pharmaceuticals、Teva Pharmaceutical Industries Ltd.） ・結論

Opioid Drugs can act on the pain central system in the human brain, brainstem and other tissues, thus exerting a strong downward pain suppression effect.
Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons of the spinal dorsal horn in the human body, and can also inhibit the Released, effectively preventing pain sensations from flowing into the brain.

Market Analysis and Insights: Global Opioid Drugs Market
The global Opioid Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Drugs market.

Global Opioid Drugs Scope and Market Size
Opioid Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others

Segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson＆Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Buprenorphine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Morphine
1.2.6 Oxycodone
1.2.7 Tramadol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Opioid Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anesthesia
1.3.3 Pain relief
1.3.4 Cough suppression
1.3.5 Diarrhea suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Opioid Drugs Market Perspective (2016-2027)
2.2 Opioid Drugs Growth Trends by Regions
2.2.1 Opioid Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Opioid Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Opioid Drugs Industry Dynamic
2.3.1 Opioid Drugs Market Trends
2.3.2 Opioid Drugs Market Drivers
2.3.3 Opioid Drugs Market Challenges
2.3.4 Opioid Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Opioid Drugs Players by Revenue
3.1.1 Global Top Opioid Drugs Players by Revenue (2016-2021)
3.1.2 Global Opioid Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid Drugs Revenue
3.4 Global Opioid Drugs Market Concentration Ratio
3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2020
3.5 Opioid Drugs Key Players Head office and Area Served
3.6 Key Players Opioid Drugs Product Solution and Service
3.7 Date of Enter into Opioid Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Drugs Breakdown Data by Type
4.1 Global Opioid Drugs Historic Market Size by Type (2016-2021)
4.2 Global Opioid Drugs Forecasted Market Size by Type (2022-2027)

5 Opioid Drugs Breakdown Data by Application
5.1 Global Opioid Drugs Historic Market Size by Application (2016-2021)
5.2 Global Opioid Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Opioid Drugs Market Size (2016-2027)
6.2 North America Opioid Drugs Market Size by Type
6.2.1 North America Opioid Drugs Market Size by Type (2016-2021)
6.2.2 North America Opioid Drugs Market Size by Type (2022-2027)
6.2.3 North America Opioid Drugs Market Size by Type (2016-2027)
6.3 North America Opioid Drugs Market Size by Application
6.3.1 North America Opioid Drugs Market Size by Application (2016-2021)
6.3.2 North America Opioid Drugs Market Size by Application (2022-2027)
6.3.3 North America Opioid Drugs Market Size by Application (2016-2027)
6.4 North America Opioid Drugs Market Size by Country
6.4.1 North America Opioid Drugs Market Size by Country (2016-2021)
6.4.2 North America Opioid Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Opioid Drugs Market Size (2016-2027)
7.2 Europe Opioid Drugs Market Size by Type
7.2.1 Europe Opioid Drugs Market Size by Type (2016-2021)
7.2.2 Europe Opioid Drugs Market Size by Type (2022-2027)
7.2.3 Europe Opioid Drugs Market Size by Type (2016-2027)
7.3 Europe Opioid Drugs Market Size by Application
7.3.1 Europe Opioid Drugs Market Size by Application (2016-2021)
7.3.2 Europe Opioid Drugs Market Size by Application (2022-2027)
7.3.3 Europe Opioid Drugs Market Size by Application (2016-2027)
7.4 Europe Opioid Drugs Market Size by Country
7.4.1 Europe Opioid Drugs Market Size by Country (2016-2021)
7.4.2 Europe Opioid Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Opioid Drugs Market Size (2016-2027)
8.2 Asia-Pacific Opioid Drugs Market Size by Type
8.2.1 Asia-Pacific Opioid Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid Drugs Market Size by Application
8.3.1 Asia-Pacific Opioid Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid Drugs Market Size by Region
8.4.1 Asia-Pacific Opioid Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Opioid Drugs Market Size (2016-2027)
9.2 Latin America Opioid Drugs Market Size by Type
9.2.1 Latin America Opioid Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Opioid Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Opioid Drugs Market Size by Type (2016-2027)
9.3 Latin America Opioid Drugs Market Size by Application
9.3.1 Latin America Opioid Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Opioid Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Opioid Drugs Market Size by Application (2016-2027)
9.4 Latin America Opioid Drugs Market Size by Country
9.4.1 Latin America Opioid Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Opioid Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Opioid Drugs Market Size (2016-2027)
10.2 Middle East & Africa Opioid Drugs Market Size by Type
10.2.1 Middle East & Africa Opioid Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid Drugs Market Size by Application
10.3.1 Middle East & Africa Opioid Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid Drugs Market Size by Country
10.4.1 Middle East & Africa Opioid Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Details
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2016-2021)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Cipher Pharmaceutical Inc.
11.2.1 Cipher Pharmaceutical Inc. Company Details
11.2.2 Cipher Pharmaceutical Inc. Business Overview
11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2016-2021)
11.2.5 Cipher Pharmaceutical Inc. Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Opioid Drugs Introduction
11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2016-2021)
11.3.5 Daiichi Sankyo Recent Development
11.4 Johnson＆Johnson
11.4.1 Johnson＆Johnson Company Details
11.4.2 Johnson＆Johnson Business Overview
11.4.3 Johnson＆Johnson Opioid Drugs Introduction
11.4.4 Johnson＆Johnson Revenue in Opioid Drugs Business (2016-2021)
11.4.5 Johnson＆Johnson Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Opioid Drugs Introduction
11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2016-2021)
11.5.5 Lupin Limited Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Opioid Drugs Introduction
11.6.4 Pfizer Revenue in Opioid Drugs Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Details
11.7.2 Sun Pharmaceuticals Business Overview
11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2016-2021)
11.7.5 Sun Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Details
11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2016-2021)
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Buprenorphine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Morphine
Table 6. Key Players of Oxycodone
Table 7. Key Players of Tramadol
Table 8. Key Players of Others
Table 9. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Opioid Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Opioid Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Opioid Drugs Market Share by Regions (2016-2021)
Table 13. Global Opioid Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Opioid Drugs Market Share by Regions (2022-2027)
Table 15. Opioid Drugs Market Trends
Table 16. Opioid Drugs Market Drivers
Table 17. Opioid Drugs Market Challenges
Table 18. Opioid Drugs Market Restraints
Table 19. Global Opioid Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Opioid Drugs Market Share by Players (2016-2021)
Table 21. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Drugs as of 2020)
Table 22. Ranking of Global Top Opioid Drugs Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Opioid Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Opioid Drugs Product Solution and Service
Table 26. Date of Enter into Opioid Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Opioid Drugs Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Opioid Drugs Revenue Market Share by Type (2016-2021)
Table 30. Global Opioid Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Opioid Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Opioid Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Opioid Drugs Revenue Market Share by Application (2016-2021)
Table 34. Global Opioid Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Opioid Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Opioid Drugs Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Opioid Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Opioid Drugs Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Opioid Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Opioid Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Opioid Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Opioid Drugs Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Opioid Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Opioid Drugs Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Opioid Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Opioid Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Opioid Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Opioid Drugs Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Opioid Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Opioid Drugs Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Opioid Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Opioid Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Opioid Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Opioid Drugs Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Opioid Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Opioid Drugs Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Opioid Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Opioid Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Opioid Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Opioid Drugs Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Opioid Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Opioid Drugs Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Opioid Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Opioid Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Opioid Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 66. Acura Pharmaceuticals Company Details
Table 67. Acura Pharmaceuticals Business Overview
Table 68. Acura Pharmaceuticals Opioid Drugs Product
Table 69. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 70. Acura Pharmaceuticals Recent Development
Table 71. Cipher Pharmaceutical Inc. Company Details
Table 72. Cipher Pharmaceutical Inc. Business Overview
Table 73. Cipher Pharmaceutical Inc. Opioid Drugs Product
Table 74. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 75. Cipher Pharmaceutical Inc. Recent Development
Table 76. Daiichi Sankyo Company Details
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo Opioid Drugs Product
Table 79. Daiichi Sankyo Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 80. Daiichi Sankyo Recent Development
Table 81. Johnson＆Johnson Company Details
Table 82. Johnson＆Johnson Business Overview
Table 83. Johnson＆Johnson Opioid Drugs Product
Table 84. Johnson＆Johnson Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 85. Johnson＆Johnson Recent Development
Table 86. Lupin Limited Company Details
Table 87. Lupin Limited Business Overview
Table 88. Lupin Limited Opioid Drugs Product
Table 89. Lupin Limited Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 90. Lupin Limited Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Opioid Drugs Product
Table 94. Pfizer Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Sun Pharmaceuticals Company Details
Table 97. Sun Pharmaceuticals Business Overview
Table 98. Sun Pharmaceuticals Opioid Drugs Product
Table 99. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 100. Sun Pharmaceuticals Recent Development
Table 101. Teva Pharmaceutical Industries Ltd. Company Details
Table 102. Teva Pharmaceutical Industries Ltd. Business Overview
Table 103. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2016-2021) & (US$ Million)
Table 104. Teva Pharmaceutical Industries Ltd. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Drugs Market Share by Type: 2020 VS 2027
Figure 2. Buprenorphine Features
Figure 3. Fentanyl Features
Figure 4. Hydrocodone Features
Figure 5. Morphine Features
Figure 6. Oxycodone Features
Figure 7. Tramadol Features
Figure 8. Others Features
Figure 9. Global Opioid Drugs Market Share by Application: 2020 VS 2027
Figure 10. Anesthesia Case Studies
Figure 11. Pain relief Case Studies
Figure 12. Cough suppression Case Studies
Figure 13. Diarrhea suppression Case Studies
Figure 14. Deaddiction Case Studies
Figure 15. Others Case Studies
Figure 16. Opioid Drugs Report Years Considered
Figure 17. Global Opioid Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Opioid Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Opioid Drugs Market Share by Regions: 2020 VS 2027
Figure 20. Global Opioid Drugs Market Share by Regions (2022-2027)
Figure 21. Global Opioid Drugs Market Share by Players in 2020
Figure 22. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Drugs as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2020
Figure 24. Global Opioid Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Opioid Drugs Revenue Market Share by Type (2022-2027)
Figure 26. North America Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Opioid Drugs Market Share by Type (2016-2027)
Figure 28. North America Opioid Drugs Market Share by Application (2016-2027)
Figure 29. North America Opioid Drugs Market Share by Country (2016-2027)
Figure 30. United States Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Opioid Drugs Market Share by Type (2016-2027)
Figure 34. Europe Opioid Drugs Market Share by Application (2016-2027)
Figure 35. Europe Opioid Drugs Market Share by Country (2016-2027)
Figure 36. Germany Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Opioid Drugs Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Opioid Drugs Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Opioid Drugs Market Share by Region (2016-2027)
Figure 46. China Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Opioid Drugs Market Share by Type (2016-2027)
Figure 54. Latin America Opioid Drugs Market Share by Application (2016-2027)
Figure 55. Latin America Opioid Drugs Market Share by Country (2016-2027)
Figure 56. Mexico Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Opioid Drugs Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Opioid Drugs Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Opioid Drugs Market Share by Country (2016-2027)
Figure 62. Turkey Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Opioid Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 66. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 67. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 68. Johnson＆Johnson Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 69. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 71. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 72. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---